Get the full picture
Sign in to uncover key details.
NA
Vice President, Clinical Development
Get the full picture
Sign in to uncover key details.
Biond Biologics
Blood & Organ Banks · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Misgave Industrial Park, Tel Aviv, Israe...Phone Number
+972 48844337Website
www.biondbio.comRevenue
<$5 MillionIndustry
About Biond Biologics
Biond Biologics specializes in innovative immunotherapies for oncology, focusing on developing first-in-class biologics that address immune evasion mechanisms. Their pipeline includes three clinical-stage oncology programs and various discovery and preclinical programs targeting immune-mediated diseases. Key products include BND-22, an ILT2 blocking antibody in Phase 2 trials, BND-67, a CD28 shedding antibody in Phase 1 studies, and BND-35, an ILT3 targeting antibody. The company aims to restore immune homeostasis and enhance anti-tumor immunity for patients with solid tumors.Explore more
Biond Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Biond Biologics Tech Stack
A closer look at the technologies used by Biond Biologics
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Biond Biologics
Sign Up For FreeTo access detailed company insights
Biond Biologics specializes in innovative immunotherapies for oncology, focusing on developing first-in-class biologics that address immune evasion mechanisms. Their pipeline includes three clinical-stage oncology programs and various discovery and preclinical programs targeting immune-mediated diseases. Key products include BND-22, an ILT2 blockin... Read More
